Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01947179 · ClinicalTrials.gov registry record · NA

Cognitive Anxiety Sensitivity Treatment for Suicide

A NA study of Anxiety, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT01947179: Completed NA study of Anxiety, sponsored by Florida State University.

NCT01947179 is a NA study of Anxiety that has completed, run by Florida State University. The registered enrollment target is 108 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01947179, a NA study of Anxiety, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the effectiveness and usability of a computer-based treatment for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with several negative mental health outcomes such as suicidal ideation, substance use disorders, and Post-Traumatic Stress Disorder.

Primary Outcome

The ASI is a 16-item self-report measure of anxiety sensitivity. Each item consists of a possible negative consequence of anxiety symptoms. The scale assesses three AS subfactors including cognitive, physical, and social concerns. The measure has shown good psychometric properties.

Conditions Studied

Interventions

  • BEHAVIORAL Anxiety Risk Reduction

Study Locations (1)

Florida

  • Florida State University - Tallahassee

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2011-09
Est. Completion 2013-02
Phase NA
Florida State University

219 total trials

What the finished NCT01947179 record still lists

NCT01947179 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Anxiety Risk Reduction is the first listed.

NCT01947179 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01947179 about?

NCT01947179 is a clinical study titled "Cognitive Anxiety Sensitivity Treatment for Suicide". The purpose of this study is to test the effectiveness and usability of a computer-based treatment for mood and anxiety relevant risk factors. The target of the treatment is related to cognitive stress, which has been shown to be associated with several negative mental health outcomes such as suicid...

What is the current status of trial NCT01947179?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2011-09. Estimated completion is 2013-02.

What conditions does trial NCT01947179 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT01947179?

The interventions under investigation include: Anxiety Risk Reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT01947179?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01947179 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01947179's enrollment target sits among peer trials

108 155th of 364 higher than 208 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01947179, the US trial registry maintained by the National Library of Medicine. NCT01947179 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.